Cite
Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real‐world chronic hepatitis C patients cohort.
MLA
Idilman, Ramazan, et al. “Low Recurrence Rate of Hepatocellular Carcinoma Following Ledipasvir and Sofosbuvir Treatment in a Real‐world Chronic Hepatitis C Patients Cohort.” Journal of Viral Hepatitis, vol. 26, no. 6, June 2019, pp. 666–74. EBSCOhost, https://doi.org/10.1111/jvh.13075.
APA
Idilman, R., Demir, M., Aladag, M., Erol, C., Cavus, B., Iliaz, R., Koklu, H., Cakaloglu, Y., Sahin, M., Ersoz, G., Koksal, İ., Karasu, Z., Ozgenel, M., Turan, İ., Gunduz, F., Ataseven, H., Akdogan, M., Kiyici, M., Koksal, A. S., & Akhan, S. (2019). Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real‐world chronic hepatitis C patients cohort. Journal of Viral Hepatitis, 26(6), 666–674. https://doi.org/10.1111/jvh.13075
Chicago
Idilman, Ramazan, Mehmet Demir, Murat Aladag, Cihan Erol, Bilger Cavus, Raim Iliaz, Hayrettin Koklu, et al. 2019. “Low Recurrence Rate of Hepatocellular Carcinoma Following Ledipasvir and Sofosbuvir Treatment in a Real‐world Chronic Hepatitis C Patients Cohort.” Journal of Viral Hepatitis 26 (6): 666–74. doi:10.1111/jvh.13075.